TP53 and non-small cell lung carcinoma: In human NSCLC cell lines that harbor wild-type p53, it has been shown that a small molecule that disrupts p53 binding, which activates p53 and promotes apoptosis via the induction of downstream target pro-apoptotic BH3-only genes, Noxa and PUMA [82].